The mission of the Institut Jules Bordet's Department of Internal Medicine is to assume responsibilitiy regarding:
- Organising, with senior doctors from other specialities, the hospital's medical activity and support for undergraduate and postgraduate students
- Coordinating the various sister medical specialities of internal medicine, with the exception of those represented by departments concerned specifically with medical oncology and haematology.
- Intensive care
- The oncological emergencies room
- The infectious diseases clinic.
- Providing training in internal medicine for medical students and doctors training to be a specialist during the core years of internal medicine studies and higher training in internal medicine.
The Department of Internal Medicine offers expertise in the various fields of internal medicine while specialising in caring for patients suffering from oncological diseases:
- Oncological intensive care
- Oncological emergencies
- Infectious diseases
- Other medical specialities such as pnuemology
Every autumn the Department of Internal Medicine organizes an international meeting in French that is dedicated specifically to the severe complications that occur in patients suffering from a cancerous disease.
The department managers have developed two websites dedicated to cancer complications: www.oncorea.com for acute problems and www.pneumocancero.com for chronic problems (with particular focus on thoracic oncology).
The department has a continuous intake of medical students (Master's) and trainee specialists (internal medicine and sister disciplines) who follow training courses in internal medicine and in the department's more specific sectors. They are supported during seminars and specific tours.
In addition, the responsible doctors participate actively in the teaching of medical semiology, internal medicine clinical practice for the ULB's Master's in medicine, and the ULB's Master's specialising in internal medicine.
Research projects
Project 1 (in progress)
L’inflammation a-t-elle une implication significative dans l’évolution du cancer bronchique ?
- Project initiator: Dr Anne-Pascale Meert
- Financing: Intensive oncological care unit
Project 2 (in progress)
COHESIS : Collaboration and Outreach in Hematological patients with/without Sepsis
- Project initiator : Dr Anne-Pascale Meert
- Financing : Amis de l’Institut Bordet
- Collaborations : GrrrOH, NINE-I, HEMICU, DISPROPICUS, University of Ghent, University of Rotterdam
Project 3 (in progress)
IMMUNO-REA : Caractéristiques et prise en charge des patients atteints d’une tumeur solide traités par immunothérapie admis en réanimation
- Project initiator : Dr Anne-Pascale Meert
- Financing: Intensive oncological care unit
- Collaboration: GrrrOH
Project 4 (in progress)
Recommandations de pratique clinique pour le patient atteint d’une affection maligne admis en unité de soins intensifs.
- Project initiator : Dr Anne-Pascale Meert
- Financing: Intensive oncological care unit
Our team
Head of department
Prof. Anne-Pascale Meert
(Caroline Gustin : Secretary)
Intensive care and oncological emergencies
Prof. Thierry Berghmans, head of clinic
Dr Bogdan Grigoriu, deputy head of clinic
Dr Vito Fontana, résident
Infectious diseases clinic
Prof. Michael Aoun, head of clinic
Dr Aspasia Georgala
Dr Angela Loizidou
Medical speciality
Dr Bogdan Grigoriu, pulmonology
Dr Nicolas Mavroudakis, neurology
Dr Lorenzo Ferlini, neurology
Dr François Delhaye, cardiology
Dr Nouar Elias, cardiology
Dr Costante, endocrinology
Dr Simenon, rhumatology
22/01/2020
Scientific publications
Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience?
Authors : Costante G
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 3-8
Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium.
Authors : Koubaity M, Lechon AS, Amighi K, Van Nuffelen M, Moreau M, Meert AP, De Vriese C
Year : 2021
Journal : Support Care Cancer
[Perioperative treatment for resected non-small cell lung cancer: Which option in 2020?]
Authors : Coureau M, Berghmans T
Year : 2021
Journal : Rev Mal Respir
Risk factors for imminent fractures: a substudy of the FRISBEE cohort.
Authors : Iconaru L, Moreau M, Baleanu F, Kinnard V, Charles A, Mugisha A, Surquin M, Benoit F, Karmali R, Paesmans M, Body JJ, Bergmann P
Year : 2021
Journal : Osteoporos Int
Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.
Authors : Chicoisneau M, Paesmans M, Ameye L, Sculier JP, Meert AP
Year : 2021
Journal : Acta Clin Belg
Pages : 1-9